During the past decade, Hopitaux Civils de Colmar conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 11 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 6 clinical trials were completed. i.e. 19.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopitaux Civils de Colmar" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 26 trials, followed by "Federation Francophone de Cancerologie Digestive" with 20 trials sponsored, "UNICANCER" with 14 trials sponsored, "University Hospital, Strasbourg, France" with 9 trials sponsored and "Nantes University Hospital" with 9 trials sponsored. Other sponsors include 90 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopitaux Civils de Colmar" #1 collaborator was "UNICANCER" with 4 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 3 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials as a collaborator and "Intergroupe Francophone de Cancerologie Thoracique" with 3 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 111 trials.

According to Clinical.Site data, the most researched conditions in "Hopitaux Civils de Colmar" are "Colorectal Cancer" (10 trials), "Non Small Cell Lung Cancer Metastatic" (5 trials), "Prostate Cancer" (5 trials), "Alzheimer Disease" (4 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Hopitaux Civils de Colmar" in a lesser frequency.

Most popular intervention types in "Hopitaux Civils de Colmar" are "Drug" (112 trials), "Other" (31 trials), "Procedure" (19 trials), "Biological" (11 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "fluorouracil" (10 trials), "radiation therapy" (8 trials), "Bevacizumab" (7 trials) and "Gemcitabine" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hopitaux Civils de Colmar" are 151 trials for "All" genders, 14 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Hopitaux Civils de Colmar". undefined are not yet recruiting, 34 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 91 completed trials in Hopitaux Civils de Colmar, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hopitaux Civils de Colmar, 4 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 17 trials that are defined as “Not Applicable".